Impact of Uterine Fibroids on Women's Fertility
The Effects of Uterine Fibroids on Pregnancy in Women
Tongji Hospital · NCT06020924
This study looks at how uterine fibroids might affect pregnancy rates in women aged 20-50 who are struggling with infertility.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1658 (estimated) |
| Ages | 20 Years to 50 Years |
| Sex | Female |
| Sponsor | Tongji Hospital (other) |
| Locations | 1 site (Wuhan, Hubei) |
| Trial ID | NCT06020924 on ClinicalTrials.gov |
What this trial studies
This observational study investigates how uterine fibroids may affect pregnancy rates in women diagnosed with infertility. It involves a retrospective cohort analysis of women aged 20-50, comparing those with uterine fibroids to those without, to evaluate the influence of fibroids on fertility outcomes. The study aims to gather comprehensive clinical data to better understand the relationship between fibroids and infertility, which is a growing concern worldwide. By analyzing various factors contributing to infertility, the research seeks to shed light on the complexities of female reproductive health.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 20-50 who have been diagnosed with uterine fibroids and are either infertile or non-infertile.
Not a fit: Patients with severe infectious diseases, active rheumatic immune diseases, or a history of malignant tumors may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the role of uterine fibroids in infertility, potentially guiding treatment options for affected women.
How similar studies have performed: While the relationship between uterine fibroids and infertility has been explored in other studies, this specific observational approach may provide novel insights into the issue.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age: 20-50 years 2. Diagnosed with uterine fibroids (by ultrasound or pathology) combined with infertile or non-infertile patients 3. Complete clinical data. Exclusion Criteria: 1. Severe infectious disease or rheumatic immune disease active stage 2. Previous history of malignant tumors 3. Incomplete clinical data.
Where this trial is running
Wuhan, Hubei
- Huazhong University of Science and Technology — Wuhan, Hubei, China (RECRUITING)
Study contacts
- Principal investigator: Shixuan Wang — Huazhong University of Science and Technology, Wuhan, Hubei, China, 430000
- Study coordinator: Shixuan Wang
- Email: shixuanwang@tjh.tjmu.edu.cn
- Phone: 86-27-83663078
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Female Infertility, Uterine Fibroid, Infertility, Uterine fibroids, Pregnancy rate